Tom Branna, Editorial Director04.30.21
Cosmetic manufacturers are bracing for a flurry of regulations that went into effect today in China. The National Medical Products Administration (NMPA) has issued “Cosmetics Efficacy Claim Evaluation Standards," “The Technical Guidelines for Cosmetic Safety Assessment" and “Cosmetic Classification Rules and Catalog," as well as Provisions on Management of Registration and Notification Dossiers for Cosmetics and Cosmetic Ingredients. All are designed to guide the implementation of Cosmetics Supervision and Administration Regulations (CSAR).
According to Happi Correspondent Ally Dai, getting the products registered in the NMPA system is the top priority for many players now, due to much stricter new requirements for product registration and notification.
The Inventory of Existing Cosmetics Ingredients in China (IECIC), adds three new lists: Highest historical usage of rinse-off products (%), Highest historical usage of leave-on products (%) and Remarks on ingredient safety reviews (restricted/already prohibited/to be amended as prohibited), to be used as the evidence and reference of safety assessment, according to the NMPA.
In addition, regulators marked three cannabis-based ingredients are marked as “to be amended as prohibited.”
"Their cosmetic applications can continue for the time being, and a final decision is to be made later—that's vague," noted Dai.
According to Happi Correspondent Ally Dai, getting the products registered in the NMPA system is the top priority for many players now, due to much stricter new requirements for product registration and notification.
The Inventory of Existing Cosmetics Ingredients in China (IECIC), adds three new lists: Highest historical usage of rinse-off products (%), Highest historical usage of leave-on products (%) and Remarks on ingredient safety reviews (restricted/already prohibited/to be amended as prohibited), to be used as the evidence and reference of safety assessment, according to the NMPA.
In addition, regulators marked three cannabis-based ingredients are marked as “to be amended as prohibited.”
"Their cosmetic applications can continue for the time being, and a final decision is to be made later—that's vague," noted Dai.
